Serial Number 99617061
630

Registration Progress

Application Filed
Jan 27, 2026
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

Basic Information

Serial Number
99617061
Filing Date
January 27, 2026
Drawing Code
2

Status Summary

Current Status
Active
Status Code
630
Status Date
Jan 27, 2026
Application
Pending
Classes
042 044

Rights Holder

Neurocrine Biosciences, Inc.

03
Address
6027 Edgewood Bend Court
San Diego, CA 92130

Ownership History

Neurocrine Biosciences, Inc.

Original Applicant
03
San Diego, CA

Neurocrine Biosciences, Inc.

Original Applicant
03
San Diego, CA

Legal Representation

Attorney
Allison Strickland Ricketts

Application History

4 events
Date Code Type Description Documents
Jan 27, 2026 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 27, 2026 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 27, 2026 NWAP I NEW APPLICATION ENTERED Loading...
Jan 27, 2026 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia, and evaluating epidemiological results for treatments for neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia
Class 044
Providing medical information; providing medical information relating to therapies and treatments for neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia

Additional Information

Design Mark
The mark consists of two interconnecting open rhombuses, the open edge of each rhombus ending in an arrowhead.
Design Mark
The mark consists of two interconnecting open rhombuses, the open edge of each rhombus ending in an arrowhead.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042 044